Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Learn more about HealthTree
Targeted and Immunologic Treatments for AML image

Targeted and Immunologic Treatments for AML

Can't make it to the event?
We send a recording to all registered participants of the event!
Oct 14, 2026
12:30PM - 01:30PM EDT
Online Event
Overview

Immunological treatments are growing in the world of AML, providing more treatment opportunities. Hear from Dr. Eytan Stein as he discusses new developments in the world of targeted and immunologic treatments for AML. There will be a Q&A session at the end so come with questions!

 

Agenda
12:30 PM
Introduction
Eliza Prickett, MPH

Eliza introduces the agenda of the event and our featured speaker Dr. Eytan Stein

12:35 PM
Presentation
Eytan Stein, MD

Dr. Stein talks about immunologic treatment for AML patients

1:05 PM
Questions and Answers
Audience

Come with your questions and we'll answer them!

Speakers & Moderators
Healthtree contact Eliza Prickett, MPH

Eliza Prickett, MPH

Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings, including Americorps and Utah Health Department. When not in office, Eliza enjoys reading, writing and learning new things about the world.
Healthtree contact Eytan Stein, MD

Eytan Stein, MD

Dr. Stein is the Chief of Leukemia Service and the Director of the Program for Drug Development in Leukemia at Memorial Sloan Kettering Cancer Center. He is a hematologist-oncologist who specializes in caring for people with acute and chronic leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms. He is dedicated to providing patients with the best care for their unique situations using a personalized treatment plan that fits all of the patient's needs. Dr. Stein is known amongst his patients as a provider who takes the time to really listen to all of his patients and explain their disease to them in easy-to-understand terms. Dr. Stein is active in clinical research surrounding new approaches to treating acute myeloid leukemia. Through the numerous publications and studies he's involved in, Dr. Stein shows that he puts the patient and their needs at the forefront as he helps to move research forward in the field of leukemia.